UnitedHealth Q4 2025 Earnings Analysis

# Beta Finch Podcast Script: UnitedHealth Q4 2025 Earnings**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we turn corporate speak into plain talk. I'm Alex.**JORDAN:** And I'm Jordan. Today we're diving into UnitedHealth's Q4 2025 results, and wow - there's a lot to unpack here.**ALEX:** Before we get started, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.**JORDAN:** Right, and speaking of unpacking - UnitedHealth just delivered what I'd call a "everything but the kitchen sink" quarter. They beat expectations slightly with adjusted EPS of $16.35, but there's this massive $1.6 billion charge lurking underneath.**ALEX:** Yeah, that charge is wild. It's like getting three different bills at once - $800 million related to that cyberattack cleanup, a $440 million gain from selling off assets, and then a whopping $2.5 billion restructuring charge. It's clear they're doing some serious spring cleaning.**JORDAN:** What caught my attention is how transparent CEO Stephen Hemsley was about this being a "new age" for the company. They're essentially admitting they need to get back to basics while investing heavily in AI - we're talking $1.5 billion in 2026 alone.**ALEX:** Let's talk numbers first. Revenue hit nearly $448 billion, up 12% year-over-year, which is solid. But the real story is in the 2026 guidance - they're projecting adjusted EPS of greater than $17.75, which represents at least 8.6% growth.**JORDAN:** That guidance is interesting because it's what I'd call "cautiously optimistic." They're expecting double-digit improvements at UnitedHealthcare but only low-to-high single-digit growth across the Optum segments. It tells me they're being realistic about their turnaround timeline.**ALEX:** The Medicare Advantage story is probably the biggest concern for investors. Tim Noel basically said they're planning to lose 1.3 to 1.4 million Medicare Advantage members in 2026. That's not a typo - they're intentionally shrinking to focus on profitability over growth.**JORDAN:** And then yesterday's rate notice for 2027 was apparently even worse than expected. Noel called it "disappointing" and warned of "meaningful benefit reductions" for seniors. When a healthcare executive is that blunt about government rates, you know it's bad.**ALEX:** What's their strategy to deal with this? It sounds like they're doubling down on margin recovery. They expect Medicare margins to improve by about 50 basis points in 2026, but they're essentially trading membership for profitability.**JORDAN:** The Optum turnaround is where things get really interesting. Patrick Conway, the new Optum CEO, outlined some pretty dramatic changes. They've narrowed their provider network by 20%, streamlined risk membership by 15%, and consolidated down from 18 different electronic medical record systems to just three.**ALEX:** That EMR consolidation alone shows you how scattered they were. Imagine trying to implement AI tools across 18 different systems - it's like trying to conduct an orchestra where every musician is reading different sheet music.**JORDAN:** Speaking of AI, they claim 80% of member calls now use AI tools, and they're expecting nearly $1 billion in AI-enabled cost reductions in 2026. That's not just efficiency gains - that's transformational if they can pull it off.**ALEX:** Now let's talk about what came up in the Q&A, because that's where executives sometimes reveal what they're really thinking. One analyst asked about the bottom of the Medicare Advantage cycle, and you could sense the frustration in management's response.**JORDAN:** Right, they're clearly not happy with the regulatory environment. Hemsley mentioned $130 billion in funding reductions over the past three yThis episode includes AI-generated content.